Sandbox 126
From Proteopedia
(Difference between revisions)
Line 7: | Line 7: | ||
- | ==Background== | + | == Background == |
- | + | Transpeptidases (TP), also known as penicillin-binding proteins (PBP), catalyze the cross-linking of peptidoglycan polymers during bacterial cell wall synthesis. The natural transpeptidase substrate is the D-Ala-D-Ala peptidoglycan side chain terminus. Beta-lactam (β-lactam) antibiotics, which include penicillins, cephalosporins and carbapenems, bind and irreversibly inhibit transpeptidases by mimicking the D-Ala-D-Ala substrate, resulting in the inhibition of cell wall synthesis and ultimately bacterial cell growth. Overuse and misuse of β-lactams has led to the generation of methicillin- resistant Staphylococcus aureus (MRSA) isolates that have acquired an alternative transpeptidase, PBP2a, which is neither bound nor inhibited by β- lactams. MRSA isolates are resistant to all β-lactams, and are often only susceptible to “last resort antibiotics”, such as vancomycin. Recently, two cephalosporins - ceftobiprole and ceftaroline - that bind and inhibit PBP2a have been developed. The Hostos-Lincoln Academy Students Modeling A Research Topic (SMART) Team generated a model of the PBP2a/ceftobiprole complex (PDB 4DKI) using 3D printing technology to illustrate the mechanism of action of ceftobiprole. Supported by a grant from the Camille and Henry Dreyfus Foundation. | |
- | + | ||
<scene name='37/372726/Pbp2a_with_residues/1'>PBP2a and active site residues</scene> | <scene name='37/372726/Pbp2a_with_residues/1'>PBP2a and active site residues</scene> | ||
Line 16: | Line 15: | ||
<scene name='37/372726/Ceftobiprole/2'>Ceftobiprole</scene> | <scene name='37/372726/Ceftobiprole/2'>Ceftobiprole</scene> | ||
- | <scene name='37/372726/Ceftobiprole/ | + | <scene name='37/372726/Ceftobiprole/4'>Ceftobiproles R2 Group</scene> |
==How does PBP2a work== | ==How does PBP2a work== |
Revision as of 17:37, 30 July 2013
|